Invitation to presentation of Electrolux Group Q2 report

On 18thof July, Electrolux Group will publish the results for the second quarter of 2025, at approx. 07.00 CET. Media, investors and analysts are invited to a simultaneous video webcast and telephone conference on the same day following the release of the results, starting at 09.00 CET where Yannick Fierling, President and CEO, together with

Ping An Good Doctor Selected for First Batch of “Open-Source LLMs+” Innovation Application Cases, Showcasing Medical AI Scenario Implementation

The “Global Digital Economy Conference – Cloud-Intelligence-Computing Security Forum,” also known as the third “SecGo Security Forum,” was successfully held today in Beijing. The event was organized by the Global Digital Economy Conference Organizing Committee and co-hosted by the China Academy of Information and Communications Technology (“CAICT”) and the China Communications Standards Association. During the

AB Science: Masitinib receives FDA and EMA authorization for confirmatory phase 3 trial in metastatic castrate-resistant prostate cancer

(Paris:AB), PRESS RELEASE MASITINIB RECEIVES FDA AND EMA AUTHORIZATION FOR CONFIRMATORY PHASE 3 TRIAL IN METASTATIC CASTRATE-RESISTANT PROSTATE CANCER, WITH BIOMARKER-DRIVEN PATIENT SELECTION TARGETING POPULATION MOST LIKELY TO BENEFIT Paris, July 4, 2025, 8am CET AB Science SA (Euronext – FR0010557264 – AB) today announced that a confirmatory phase 3 trial of masitinib in metastatic

AB Science: Masitinib receives FDA and EMA authorization for confirmatory phase 3 trial in metastatic castrate-resistant prostate cancer

AB Science: Masitinib receives FDA and EMA authorization for confirmatory phase 3 trial in metastatic castrate-resistant prostate cancer GlobeNewswire July 04, 2025 PRESS RELEASE MASITINIB RECEIVES FDA AND EMA AUTHORIZATION FOR CONFIRMATORY PHASE 3 TRIAL IN METASTATIC CASTRATE-RESISTANT PROSTATE CANCER, WITH BIOMARKER-DRIVEN PATIENT SELECTION TARGETING POPULATION MOST LIKELY TO BENEFIT Paris, July 4, 2025, 8am

Touchstone Exploration Inc. Announces Employee Share Purchase Plan & PDMR Purchases

CALGARY, AB / ACCESS Newswire / July 4, 2025 / Touchstone Exploration Inc. ("Touchstone" or the "Company") (TSX:TXP)(LSE:TXP) announces the following purchases under its Employee and Non-Executive Director Share Purchase Plan. 1 Details of the person discharging managerial responsibilities / person closely associated a) Name 1. Paul R. Baay 2. Scott Budau 3. Brian Hollingshead

Aker BP: Second quarter 2025 trading update

Aker BP (OSE: AKRBP) will publish its report for the second quarter of 2025 on 15 July 2025. Today, the company provides preliminary production and sales figures for the quarter. Production and sales The company's equity production for the quarter averaged 415.0 thousand barrels of oil equivalent per day (mboepd). Due to underlift, the net

Yachiyo Engineering and NEC launch adaptation finance study in Indonesia to calculate the adaptation value of disaster prevention measures

Yachiyo Engineering Co., Ltd. (Yachiyo Engineering) and NEC Corporation (NEC) announced today the acceptance of their joint proposal for a smart city feasibility study for the Japan ASEAN Mutual Partnership (Smart JAMP) initiative under Japan's Ministry of Land, Infrastructure, Transport and Tourism. The "2025 Smart JAMP Smart City Feasibility Study" is being conducted from June

ISS wins large contract with public healthcare institution in Austria

Copenhagen , July 04, 2025 (GLOBE NEWSWIRE) — Under the new contract, ISS will deliver services across two sites, covering cleaning, logistics, and patient support. The contract will be effective from 1 February 2026. Erich Steinreiber, CEO of ISS Austria, says: “We are thrilled to enter this new partnership – the largest contract in our

ISS wins large contract with public healthcare institution in Austria

ISS wins large contract with public healthcare institution in Austria ISS, a leading global workplace experience and facility services company, has entered a new partnership with a major public healthcare institution in Austria. The contract has an annual value of approximately DKK 200 million. GlobeNewswire July 04, 2025 Copenhagen , July 04, 2025 (GLOBE NEWSWIRE)

Scroll to Top